For: | Salminen E, Palmu S, Vahlberg T, Roberts PJ, Söderström KO. Increased proliferation activity measured by immunoreactive Ki67 is associated with survival improvement in rectal/recto sigmoid cancer. World J Gastroenterol 2005; 11(21): 3245-3249 [PMID: 15929175 DOI: 10.3748/wjg.v11.i21.3245] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i21/3245.htm |
Number | Citing Articles |
1 |
Alan P. Venook, Donna Niedzwiecki, Margarita Lopatin, Xing Ye, Mark Lee, Paula N. Friedman, Wendy Frankel, Kim Clark-Langone, Carl Millward, Steven Shak, Richard M. Goldberg, Najjia N. Mahmoud, Robert S. Warren, Richard L. Schilsky, Monica M. Bertagnolli. Biologic Determinants of Tumor Recurrence in Stage II Colon Cancer: Validation Study of the 12-Gene Recurrence Score in Cancer and Leukemia Group B (CALGB) 9581. Journal of Clinical Oncology 2013; 31(14): 1775 doi: 10.1200/JCO.2012.45.1096
|
2 |
Nathaniel Melling, Charlotte Marie Kowitz, Ronald Simon, Carsten Bokemeyer, Luigi Terracciano, Guido Sauter, Jakob Robert Izbicki, Andreas Holger Marx. High Ki67 expression is an independent good prognostic marker in colorectal cancer. Journal of Clinical Pathology 2016; 69(3): 209 doi: 10.1136/jclinpath-2015-202985
|
3 |
Jetsada Ruangsuriya, Jirapast Sichaem, Apichat Tantraworasin, Somcharoen Saeteng, Phanchaporn Wongmaneerung, Angkhana Inta, Neal M. Davies, Kewalin Inthanon, Mohamed Addi. Phytochemical Profiles and Anticancer Effects of Calophyllum inophyllum L. Extract Relating to Reactive Oxygen Species Modulation on Patient-Derived Cells from Breast and Lung Cancers. Scientifica 2023; 2023: 1 doi: 10.1155/2023/6613670
|
4 |
Piotr Daniel, Malgorzata Wagrowska-Danilewicz, Marian Danilewicz, Olga Stasikowska, Ewa Malecka-Panas. Transforming growth factor beta 1 and metalloproteinase-9 overexpression in colorectal cancer (CC) and adenoma. International Journal of Colorectal Disease 2007; 22(10): 1165 doi: 10.1007/s00384-007-0296-9
|
5 |
Anas Taha, Stephanie Taha-Mehlitz, Stephanie Petzold, Sergey L. Achinovich, Dmitry Zinovkin, Bassey Enodien, Md Zahidul I. Pranjol, Eldar A. Nadyrov. Prognostic Value of Immunohistochemical Markers for Locally Advanced Rectal Cancer. Molecules 2022; 27(3): 596 doi: 10.3390/molecules27030596
|
6 |
M. S. Reimers, E. C. M. Zeestraten, T. C. van Alphen, J. W. T. Dekker, H. Putter, S. Saadatmand, G. J. Liefers, C. J. H. van de Velde, P. J. K. Kuppen. Combined analysis of biomarkers of proliferation and apoptosis in colon cancer: an immunohistochemistry-based study using tissue microarray. International Journal of Colorectal Disease 2014; 29(9): 1043 doi: 10.1007/s00384-014-1930-y
|
7 |
Anna Sadowska, Diana Sawicka, Katarzyna Godlewska, Katarzyna Guzińska-Ustymowicz, Ewa Zapora, Emilia Sokołowska, Halina Car. Beneficial Proapoptotic Effect of Heterobasidion Annosum Extract in Colorectal Cancer Xenograft Mouse Model. Molecules 2023; 28(3): 1352 doi: 10.3390/molecules28031352
|
8 |
Aldona Kasprzak. Prognostic Biomarkers of Cell Proliferation in Colorectal Cancer (CRC): From Immunohistochemistry to Molecular Biology Techniques. Cancers 2023; 15(18): 4570 doi: 10.3390/cancers15184570
|
9 |
Shibao Li, Zhiyuan Wu, Yuming Chen, Zhihua Kang, Hua Wang, Ping He, Xinju Zhang, Tingting Hu, Qunfeng Zhang, Yanqun Cai, Xiao Xu, Ming Guan. Diagnostic and prognostic value of tissue and circulating levels of Ephrin-A2 in prostate cancer. Tumor Biology 2016; 37(4): 5365 doi: 10.1007/s13277-015-4398-7
|
10 |
I. Tica Sedlar, J. Petricevic, M. Saraga-Babic, I. Pintaric, K. Vukojevic. Apoptotic pathways and stemness in the colorectal epithelium and lamina propria mucosae during the human embryogenesis and carcinogenesis. Acta Histochemica 2016; 118(7): 693 doi: 10.1016/j.acthis.2016.08.004
|
11 |
Claire Gallois, Marine Sroussi, Thierry André, Sophie Mouillet-Richard, Natacha Agueeff, Claire Mulot, Dewi Vernerey, Christophe Louvet, Jean-Baptiste Bachet, Louis-Marie Dourthe, Thibault Mazard, Marine Jary, Clélia Coutzac, Cédric Lecaille, Josep Tabernero, Jean-Luc Van Laethem, Côme Lepage, Jean-François Emile, Aurélien de Reyniès, Julien Taieb, Pierre Laurent-Puig. Prognostic Models From Transcriptomic Signatures of the Tumor Microenvironment and Cell Cycle in Stage III Colon Cancer From PETACC-8 and IDEA-France Trials. Journal of Clinical Oncology 2025; doi: 10.1200/JCO.23.02262
|
12 |
Marcello Deraco, Antonello Cabras, Dario Baratti, Shigeki Kusamura. Immunohistochemical Evaluation of Minichromosome Maintenance Protein 7 (MCM7), Topoisomerase IIα, and Ki-67 in Diffuse Malignant Peritoneal Mesothelioma Patients Using Tissue Microarray. Annals of Surgical Oncology 2015; 22(13): 4344 doi: 10.1245/s10434-015-4498-z
|
13 |
Peter M. Wilson, Pierre Bohanes, Heinz-Josef Lenz. Using The Colon Cancer Multigene Recurrence Score to Determine Risk: Prognostic Milestone or a Step in the Right Direction?. Current Colorectal Cancer Reports 2010; 6(4): 183 doi: 10.1007/s11888-010-0064-z
|
14 |
K Talvinen, H Karra, S Hurme, M Nykänen, A Nieminen, J Anttinen, T Kuopio, P Kronqvist. Securin promotes the identification of favourable outcome in invasive breast cancer. British Journal of Cancer 2009; 101(6): 1005 doi: 10.1038/sj.bjc.6605237
|
15 |
Ø Fluge, K Gravdal, E Carlsen, B Vonen, K Kjellevold, S Refsum, R Lilleng, T J Eide, T B Halvorsen, K M Tveit, A P Otte, L A Akslen, O Dahl. Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis. British Journal of Cancer 2009; 101(8): 1282 doi: 10.1038/sj.bjc.6605333
|
16 |
Hong Lei, Shan Yan, Yin He, Ning Xu, Min Zhao, Chun Yu, Hong Li, Sai Kuang, Zhan Cui, Jing Fang. Ki67 testing in the clinical management of patients with non‑metastatic colorectal cancer: Detecting the optimal cut‑off value based on the Restricted Cubic Spline model. Oncology Letters 2022; 24(6) doi: 10.3892/ol.2022.13540
|
17 |
Vitalii V. Zvirych, Yuriy I. Michailovich, Oleksandr І. Gorbach, Natalia М. Khranovska. IMMUNOHISTOCHEMICAL AND GENETIC PROGNOSTIC FACTORS OF NEOADJUVANT CHEMORADIOTHERAPY EFFICАCY IN PERSONALIZED TREATMENT OF LOCAL ADVANCED RECTAL CANCER. Wiadomości Lekarskie 2020; 73(3): 589 doi: 10.36740/WLek202003136
|
18 |
Rima A. Safadi, Basma F. Quda, Huda M. Hammad. Immunohistochemical expression of K6, K8, K16, K17, K19, maspin, syndecan-1 (CD138), α-SMA, and Ki-67 in ameloblastoma and ameloblastic carcinoma: diagnostic and prognostic correlations. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 2016; 121(4): 402 doi: 10.1016/j.oooo.2015.11.015
|
19 |
Pan Li, Zhi-Tao Xiao, Todd A. Braciak, Qing-Jan Ou, Gong Chen, Fuat S. Oduncu. Association between Ki67 Index and Clinicopathological Features in Colorectal Cancer. Oncology Research and Treatment 2016; 39(11): 696 doi: 10.1159/000450623
|
20 |
Zhao-Wen Luo, Ming-Gu Zhu, Zhi-Qiao Zhang, Feng-Jun Ye, Wen-Heng Huang, Xue-Zhang Luo. Increased expression of Ki-67 is a poor prognostic marker for colorectal cancer patients: a meta analysis. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5324-y
|
21 |
Yu-Feng Yang, Xi-Ying Zhang, Mei Yang, Ze-Hua He, Ning-Fu Peng, Shu-Rui Xie, Yan-Fang Xie. Prognostic Role of Nucleophosmin in Colorectal Carcinomas. Asian Pacific Journal of Cancer Prevention 2014; 15(5): 2021 doi: 10.7314/APJCP.2014.15.5.2021
|
22 |
Wen-juan Ma, Yukun Chen, Jian-hong Peng, Chaoming Tang, Ling Zhang, Min Liu, Shanshan Hu, Haineng Xu, Hua Tan, Yangkui Gu, Zhi-zhong Pan, Gong Chen, Zhong-guo Zhou, Rong-xin Zhang. Stage IV colon cancer patients without DENND2D expression benefit more from neoadjuvant chemotherapy. Cell Death & Disease 2022; 13(5) doi: 10.1038/s41419-022-04885-8
|
23 |
Dongdong Zhang, Lin Chen, Jixiang Wu. Endoscopic Resection of Stage T1 Colorectal Adenocarcinoma Followed by Surgical Intervention: a Single-center Retrospective Study. Journal of Gastrointestinal Cancer 2024; 55(4): 1598 doi: 10.1007/s12029-024-01109-4
|
24 |
Vikram Narang, Namrata Puri, Aminder Singh, Neena Sood, Vineeta Malhotra. COLORECTAL CANCER IN INDIA: AN ICEBERG ANALYSIS FROM NORTH INDIA. Journal of Evolution of Medical and Dental Sciences 2016; 5(03): 215 doi: 10.14260/jemds/2016/46
|
25 |
Hongtao Song, Cong Li, Rui Li, Jingshu Geng. Prognostic significance of AEG-1 expression in colorectal carcinoma. International Journal of Colorectal Disease 2010; 25(10): 1201 doi: 10.1007/s00384-010-1009-3
|
26 |
D-W Yan, D-W Li, Y-X Yang, J Xia, X-L Wang, C-Z Zhou, J-W Fan, Y-G Wen, H-C Sun, Q Wang, G-Q Qiu, H-M Tang, Z-H Peng. Ubiquitin D is correlated with colon cancer progression and predicts recurrence for stage II-III disease after curative surgery. British Journal of Cancer 2010; 103(7): 961 doi: 10.1038/sj.bjc.6605870
|
27 |
Y Apidianakis. Flies to Humans - Humans to Flies: A Virtuous Circle of Colorectal Cancer Prevention. Archives of Clinical Gastroenterology 2017; : 047 doi: 10.17352/2455-2283.000038
|
28 |
Zahra Heidari, Hamidreza Mahmoudzadeh-Sagheb, Mehdi Jahantigh, Enam Alhagh Charkhat Gorgich. Immunohistochemical Expression of Ki67 and HER2 in Colorectal Cancer Compared to Adenomatous and Normal Samples. International Journal of Cancer Management 2017; 10(11) doi: 10.5812/ijcm.12252
|
29 |
Kim M Clark-Langone, Chithra Sangli, Jayadevi Krishnakumar, Drew Watson. Translating tumor biology into personalized treatment planning: analytical performance characteristics of the Oncotype DX®Colon Cancer Assay. BMC Cancer 2010; 10(1) doi: 10.1186/1471-2407-10-691
|
30 |
C Evans, I Morrison, A G Heriot, J B Bartlett, C Finlayson, A G Dalgleish, D Kumar. The correlation between colorectal cancer rates of proliferation and apoptosis and systemic cytokine levels; plus their influence upon survival. British Journal of Cancer 2006; 94(10): 1412 doi: 10.1038/sj.bjc.6603104
|
31 |
Carlos A Rubio. Further studies on the arrest of cell proliferation in tumor cells at the invading front of colonic adenocarcinoma. Journal of Gastroenterology and Hepatology 2007; 22(11): 1877 doi: 10.1111/j.1440-1746.2007.04839.x
|
32 |
Hai‐Hong Li, Gang Zhou, Xiao‐Bing Fu, Lei Zhang. Antigen expression of human eccrine sweat glands. Journal of Cutaneous Pathology 2009; 36(3): 318 doi: 10.1111/j.1600-0560.2008.01020.x
|
33 |
Siniša Maksimović, Branislava Jakovljević, Zdenka Gojković, Zlatko Maksimović. Immunohistochemical markers: Carcinoembryonic antigen, p53, Ki-67, and proliferating cell nuclear antigen as prognostic factors for colorectal cancer. Биомедицинска истраживања 2018; 9(1): 8 doi: 10.7251/bii1801008m
|
34 |
Jussi Kasurinen, Ines Beilmann-Lehtonen, Tuomas Kaprio, Jaana Hagström, Caj Haglund, Camilla Böckelman. Phenotypic subtypes predict outcomes in colorectal cancer. Acta Oncologica 2023; 62(3): 245 doi: 10.1080/0284186X.2023.2183779
|
35 |
Jian ZHOU, Jie LI, Zengjun WANG, Changjun YIN, Wei ZHANG. Metadherin is a novel prognostic marker for bladder cancer progression and overall patient survival. Asia-Pacific Journal of Clinical Oncology 2012; 8(3) doi: 10.1111/j.1743-7563.2012.01541.x
|
36 |
Zhenyu He, Chuanbing Shi, Hao Wen, Fanglong Li, Baolin Wang, Jie Wang. The potential of carcinoembryonic antigen, p53, Ki-67 and glutathion Stransferase-π as clinico-histopathological markers for colorectal cancer. Journal of Biomedical Research 2010; 24(1): 51 doi: 10.1016/S1674-8301(10)60008-5
|
37 |
Ling Deng, Rui Wang, Mingzhong Yang, Wei Li, Ling Zou. Ameloblastic carcinoma: Clinicopathological analysis of 18 cases and a systematic review. Head & Neck 2019; 41(12): 4191 doi: 10.1002/hed.25926
|
38 |
Nara Rosana Andrade, Celina Tizuko Fujiyama Oshima, Thiago Simão Gomes, Ricardo Artigiani Neto, Nora Manoukian Forones. Imunoexpression of Ki-67 and p53 in Rectal Cancer Tissue After Treatment with Neoadjuvant Chemoradiation. Journal of Gastrointestinal Cancer 2011; 42(1): 34 doi: 10.1007/s12029-010-9225-1
|
39 |
Maximino Redondo, Cristina Abitei, Teresa Téllez, Rafael Fúnez, Teresa Pereda, Isabel Rodrigo, Ana M Betancourt, Marilina García-Aranda, Antonio Rueda, Rafael Cayetano Martínez García, María Manuela Morales Suarez-Varela, Iñaki Zabalza, Matilde Sánchez del Charco, Juan José Borrero Martín, Raimundo García del Moral, Antonio Escobar, JoséMaría Quintana, Francisco Rivas-Ruiz. Clinical–pathological characteristics and short-term follow-up associated with proliferation, apoptosis and angiogenesis in a prospective cohort of patients with colorectal tumours. Tumor Biology 2019; 41(4) doi: 10.1177/1010428319835684
|
40 |
Cristina Bidian, Gabriela Adriana Filip, Luminița David, Bianca Moldovan, Diana Olteanu, Simona Clichici, Maria-Cristina Olănescu-Vaida-Voevod, Cristian Leostean, Sergiu Macavei, Dana Maria Muntean, Mihai Cenariu, Adriana Albu, Ioana Baldea. Green Synthesized Gold and Silver Nanoparticles Increased Oxidative Stress and Induced Cell Death in Colorectal Adenocarcinoma Cells. Nanomaterials 2023; 13(7): 1251 doi: 10.3390/nano13071251
|
41 |
M. S. Reimers, E. C. M. Zeestraten, P. J. K. Kuppen, G. J. Liefers, C. J. H. van de Velde. Biomarkers in precision therapy in colorectal cancer. Gastroenterology Report 2013; 1(3): 166 doi: 10.1093/gastro/got022
|
42 |
Renuka Patil, Shanthala P R, Prema Saldanha. IMMUNOHISTOCHEMICAL MARKERS OF CLINICAL SIGNIFICANCE IN CARCINOMA OF THE COLON AND RECTUM. Journal of Evolution of Medical and Dental Sciences 2016; 5(96): 7087 doi: 10.14260/jemds/2016/1603
|
43 |
Li Bian, Tao Wang, Shao-hua Zhang, Hui-qiang Zhang, Yun-fei Guo, Ge Du, Wang Li, Shi-kai Wu, San-tai Song, Ze-fei Jiang. Ki-67 index as a prognostic factor of subsequent lapatinib-based therapy in HER2-positive metastatic breast cancer with resistance to trastuzumab. Cancer Biology & Therapy 2014; 15(4): 365 doi: 10.4161/cbt.27624
|
44 |
Meng-Yao Ji, Lei Yuan, Shi-Min Lu, Meng-Ting Gao, Zhi Zeng, Na Zhan, Yi-Juan Ding, Zheng-Ru Liu, Ping-Xiao Huang, Cheng Lu, Wei-Guo Dong. Glandular orientation and shape determined by computational pathology could identify aggressive tumor for early colon carcinoma: a triple-center study. Journal of Translational Medicine 2020; 18(1) doi: 10.1186/s12967-020-02297-w
|